SSPg, LLC. Acquire Exclusive License Rights to Prunus cerasus Oil Extract for Cosmetic Markets

Nov. 1, 2012 - PRLog -- SSPg, LLC. Acquire Exclusive License Rights to Prunus cerasus Oil Extract for Cosmetic Markets

  Chandler, AZ., November 1, 2012(Business Wire) – (news) SSPg, LLC, a collective of talented biomedical researchers who collaborate to develop therapeutic technologies used in the suppression of inflammation-associated pathology, announced today that it has formalized a relationship with the University of Debrecen, Hungary.

Under the Agreement, SSPg has been granted the exclusive License right for the patent application of the oil fraction of the sour cherry (Prunus cerasus) seed kernel filed under the PCT/HU2007/000085 & International publication WO/2008/035129, for the U.S.A, Asia & the United Kingdom. SSPg, LLC will work on a series of projects utilizing the sour cherry seed kernel oil proprietary technology to develop, market & sub-license cosmeceutical products.

SSPg, LLC, is committed to improving the quality of life for sufferers of autoimmune diseases world-wide, and to nurturing a culture which supports research into affordable preventative formulations to save the human family. SSPg LLC’s unique application of cutting edge technologies means it is at the forefront of its field with the expertise to redefine the meaning of wellbeing.

The University of Debrecen dates back to the 16th century. Debrecen Medical School is accredited by the World Health Organization, US Department of Education, The State Education Department (NY, USA), Medical Board of California, the General Medicine Council (UK), Medical Councils of Israel, Ireland, Iran and Norway.

SSPG, LLC, is currently considering additional, mutually profitable, strategic alliances with companies in related fields of endeavor. For information pertaining to the company, contact SSPG, LLC, at dr.teissier@sspg.org  or visit the Company’s web site (www.sspg.org).

This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995.  Such statements are made based on management's current expectations and beliefs.  Actual results may vary from those currently anticipated based upon a number of factors. The company undertakes no obligation to release publicly any revisions that may occur to reflect events or circumstances after the date hereof.